We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Outlines CGMPs — and Exemptions — for Outsourcing Facilities
CDER Outlines CGMPs — and Exemptions — for Outsourcing Facilities
CDER spelled out current good manufacturing practices for drug compounders that register as outsourcers in a new draft guidance — and noted when the FDA does not intend to take regulatory action.